Evolent Health, Inc. (NYSE:EVH) Chairman Frank J. Williams Sells 20,000 Shares of Stock

Evolent Health, Inc. (NYSE:EVH) Chairman Frank J. Williams sold 20,000 shares of Evolent Health stock in a transaction dated Friday, September 17th. The stock was sold at an average price of $26.27, for a total transaction of $525,400.00. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink.

Frank J. Williams also recently made the following trade(s):

  • On Friday, July 30th, Frank J. Williams sold 3,502 shares of Evolent Health stock. The stock was sold at an average price of $23.00, for a total transaction of $80,546.00.

Shares of EVH stock opened at $25.67 on Tuesday. The stock has a market cap of $2.24 billion, a price-to-earnings ratio of -30.56 and a beta of 2.40. The company has a quick ratio of 1.25, a current ratio of 1.25 and a debt-to-equity ratio of 0.34. Evolent Health, Inc. has a fifty-two week low of $9.44 and a fifty-two week high of $26.86. The firm’s 50 day moving average price is $23.86 and its two-hundred day moving average price is $21.48.

Evolent Health (NYSE:EVH) last announced its quarterly earnings results on Wednesday, August 4th. The technology company reported ($0.06) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.11) by $0.05. The firm had revenue of $222.06 million for the quarter, compared to analysts’ expectations of $216.97 million. Evolent Health had a negative net margin of 7.28% and a negative return on equity of 3.38%. On average, equities analysts forecast that Evolent Health, Inc. will post -0.27 EPS for the current fiscal year.

A number of hedge funds have recently made changes to their positions in EVH. FMR LLC lifted its position in Evolent Health by 172.2% during the second quarter. FMR LLC now owns 2,314,082 shares of the technology company’s stock valued at $48,873,000 after buying an additional 1,464,050 shares in the last quarter. Rock Springs Capital Management LP acquired a new position in Evolent Health during the first quarter valued at approximately $29,189,000. JPMorgan Chase & Co. lifted its position in shares of Evolent Health by 6.5% during the first quarter. JPMorgan Chase & Co. now owns 6,973,194 shares of the technology company’s stock worth $140,859,000 after purchasing an additional 424,359 shares in the last quarter. Bellevue Group AG lifted its position in shares of Evolent Health by 12.0% during the first quarter. Bellevue Group AG now owns 3,528,547 shares of the technology company’s stock worth $71,276,000 after purchasing an additional 379,436 shares in the last quarter. Finally, BlackRock Inc. lifted its position in shares of Evolent Health by 5.5% during the first quarter. BlackRock Inc. now owns 5,912,182 shares of the technology company’s stock worth $119,427,000 after purchasing an additional 309,949 shares in the last quarter. 94.50% of the stock is currently owned by hedge funds and other institutional investors.

A number of equities research analysts have recently commented on EVH shares. TheStreet upgraded shares of Evolent Health from a “d” rating to a “c-” rating in a report on Monday, August 23rd. Canaccord Genuity lifted their price target on shares of Evolent Health from $24.00 to $27.00 and gave the stock a “buy” rating in a report on Thursday, August 5th. Zacks Investment Research downgraded shares of Evolent Health from a “buy” rating to a “hold” rating in a report on Wednesday, August 11th. BTIG Research boosted their target price on shares of Evolent Health from $30.00 to $35.00 and gave the company a “buy” rating in a report on Monday, September 13th. Finally, Piper Sandler boosted their target price on shares of Evolent Health from $29.00 to $30.00 and gave the company an “overweight” rating in a report on Thursday, August 5th. Two equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the company. According to MarketBeat.com, Evolent Health has a consensus rating of “Buy” and an average price target of $28.40.

About Evolent Health

Evolent Health, Inc engages in the provision of health care delivery and payment services. It deals with population health management, health plan and third party administration, network performance and pharmacy benefit management, risk adjustment, analytics and performance improvement, and technology and electronic medical record integration.

Featured Article: Dividend Yield

Insider Buying and Selling by Quarter for Evolent Health (NYSE:EVH)

Receive News & Ratings for Evolent Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evolent Health and related companies with MarketBeat.com's FREE daily email newsletter.